In early June, an announcement from the US Food and Drug Administration highlighted an urgent need to secure continued supplies of certain drugs. The agency noted that more than 130 products, including 14 treatments for cancer, were in short supply.
On 13 June 13, the Health Subcommittee of the US House of Representatives then held a public hearing to highlight...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?